Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
European journal of clinical pharmacology - 78(2022), 5 vom: 03. März, Seite 895-895 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tempestilli, Massimo [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© Springer-Verlag GmbH Germany, part of Springer Nature 2022 |
|---|
| doi: |
10.1007/s00228-022-03305-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2078457892 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2078457892 | ||
| 003 | DE-627 | ||
| 005 | 20230516061655.0 | ||
| 007 | tu | ||
| 008 | 221220s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00228-022-03305-2 |2 doi | |
| 035 | |a (DE-627)OLC2078457892 | ||
| 035 | |a (DE-He213)s00228-022-03305-2-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Tempestilli, Massimo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer-Verlag GmbH Germany, part of Springer Nature 2022 | ||
| 700 | 1 | |a Stazi, Giulia Valeria |4 aut | |
| 700 | 1 | |a Maffongelli, Gaetano |4 aut | |
| 700 | 1 | |a Marini, Maria Cristina |4 aut | |
| 700 | 1 | |a Bartoli, Tommaso Ascoli |4 aut | |
| 700 | 1 | |a Ippolito, Giuseppe |4 aut | |
| 700 | 1 | |a Nicastri, Emanuele |4 aut | |
| 700 | 1 | |a Marchioni, Luisa |4 aut | |
| 700 | 1 | |a Agrati, Chiara |0 (orcid)0000-0002-5252-0927 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of clinical pharmacology |d Springer Berlin Heidelberg, 1970 |g 78(2022), 5 vom: 03. März, Seite 895-895 |w (DE-627)129300438 |w (DE-600)121960-1 |w (DE-576)01449289X |x 0031-6970 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2022 |g number:5 |g day:03 |g month:03 |g pages:895-895 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s00228-022-03305-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4277 | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2022 |e 5 |b 03 |c 03 |h 895-895 | ||